Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-02-03

FDA Approved: CHATEAL EQ — Supplemental Application (Afaxys Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for CHATEAL EQ (levonorgestrel and ethinyl estradiol) submitted by Afaxys Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHATEAL EQ (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for CHATEAL EQ (LEVONORGESTREL AND ETHINYL ESTRADIOL)